To test this hypothesis, we first determined the relationship between changes in ACAP2 expression and tumor development in the absence of miR-3656 by transfecting equivalent siACAP2 siRNA into ESCC cells. The gene discussed is ACAP2; the disease is esophageal squamous cell carcinoma.